Crystal Structures and Structure Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors

被引:122
|
作者
Tojo, Shingo [1 ]
Kohno, Tetsuya [1 ]
Tanaka, Tomoyuki [1 ]
Kamioka, Seiji [1 ]
Ota, Yosuke [1 ]
Ishii, Takayuki [1 ]
Kamimoto, Keiko [1 ]
Asano, Shigehiro [1 ]
Isobe, Yoshiaki [1 ]
机构
[1] Dainippon Sumitomo Pharma Co Ltd, Konohana Ku, Osaka 5540022, Japan
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2014年 / 5卷 / 10期
关键词
Indoleamine 2,3-dioxygenagse 1; crystal structure; induced fit; structure-based drug discovery; imidazothiazole; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN; TOLERANCE; DESIGN;
D O I
10.1021/ml500247w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Indoleamine 2,3-dioxygenase 1 (IDO1) is considered as a promising target for the treatment of several diseases, including neurological disorders and cancer. We report here the crystal structures of two IDO1/IDO1 inhibitor complexes, one of which shows that Amg-1 is directly bound to the heme iron of IDO1 with a clear induced fit. We also describe the identification and preliminary optimization of imidazothiazole derivatives as novel IDO1 inhibitors. Using our crystal structure information and structure activity relationships (SAR) at the pocket-B of IDO I, we found a series of urea derivatives as potent IDO1 inhibitors and revealed that generation of an induced fit and the resulting interaction with Phe226 and Arg231 are essential for potent IDO1 inhibitory activity. The results of this study are very valuable for understanding the mechanism of IDOI activation, which is very important for structure-based drug design (SBDD) to discover potent IDO1 inhibitors.
引用
收藏
页码:1119 / 1123
页数:5
相关论文
共 50 条
  • [21] Design, synthesis and biological evaluation of bicyclic carboxylic acid derivatives as IDO1 inhibitors
    Cai, Shi
    Yang, Xiaojun
    Chen, Pan
    Liu, Xueting
    Zhou, Jinpei
    Zhang, Huibin
    BIOORGANIC CHEMISTRY, 2020, 94
  • [22] Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors
    Yang, Rui
    Chen, Yu
    Pan, Liangkun
    Yang, Yanyan
    Zheng, Qiang
    Hu, Yue
    Wang, Yuxi
    Zhang, Liangren
    Sun, Yang
    Li, Zhongjun
    Meng, Xiangbao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (17) : 4886 - 4897
  • [23] The ups, downs and new trends of IDO1 inhibitors
    Chen, Shulun
    Tan, Jing
    Zhang, Ao
    BIOORGANIC CHEMISTRY, 2021, 110
  • [24] Discovery of IDO1 Inhibitors: From Bench to Bedside
    Prendergast, George C.
    Malachowski, William P.
    DuHadaway, James B.
    Muller, Alexander J.
    CANCER RESEARCH, 2017, 77 (24) : 6795 - 6811
  • [25] Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors
    Meininger, David
    Zalameda, Leeanne
    Liu, Yichin
    Stepan, Lara P.
    Borges, Luis
    McCarter, John D.
    Sutherland, Claire L.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2011, 1814 (12): : 1947 - 1954
  • [26] Discovery of imidazoleisoindole derivatives as potent IDO1 inhibitors: Design, synthesis, biological evaluation and computational studies
    Zou, Yi
    Wang, Fang
    Wang, Yan
    Sun, Qirui
    Hu, Yue
    Li, Yuezhen
    Liu, Wen
    Guo, Wenjie
    Huang, Zhangjian
    Zhang, Yihua
    Xu, Qiang
    Lai, Yisheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 140 : 293 - 304
  • [27] Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls
    Mammoli, Andrea
    Bianconi, Elisa
    Ruta, Luana
    Riccio, Alessandra
    Bigiotti, Carlo
    Souma, Maria
    Carotti, Andrea
    Rossini, Sofia
    Suvieri, Chiara
    Pallotta, Maria Teresa
    Grohmann, Ursula
    Camaioni, Emidio
    Macchiarulo, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [28] Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?
    Van den Eynde, Benoit J.
    van Baren, Nicolas
    Baurain, Jean-Francois
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 2020, 4 : 241 - 256
  • [29] Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1
    Markwalder, Jay A.
    Balog, Aaron J.
    Williams, David K.
    Nara, Susheel J.
    Reddy, Ratnakar
    Roy, Saumya
    Kanyaboina, Yadagiri
    Li, Xin
    Johnston, Kathy
    Fan, Yi
    Lewis, Hal
    Marsilio, Frank
    Yan, Chunhong
    Critton, David
    Newitt, John A.
    Traeger, Sarah C.
    Wu, Dauh-Rurng
    Jure-Kunkel, Maria N.
    Jayaraman, Lata
    Lin, Tai-An
    Sinz, Michael W.
    Hunt, John T.
    Seitz, Steven P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 88
  • [30] Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors
    Dong, Junmin
    Pan, Xuan
    Yang, Ying
    Zhang, Guangyan
    Xiao, Zhiyan
    Liu, Zhanzhu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 223